Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
COSMOS Pharmaceutical Corporation ( (JP:3349) ) has provided an announcement.
COSMOS Pharmaceutical Corporation reported its consolidated financial results for the three months ended August 31, 2025, showing a slight increase in net sales by 4% and a marginal growth in profit attributable to owners of the parent by 0.3%. Despite these increases, the company’s ordinary profit saw a slight decline of 0.9%. The financial forecast for the fiscal year ending May 31, 2026, anticipates continued growth in net sales and profits, albeit at a modest rate, indicating stable but slow growth in the company’s financial performance.
The most recent analyst rating on (JP:3349) stock is a Buy with a Yen11000.00 price target. To see the full list of analyst forecasts on COSMOS Pharmaceutical Corporation stock, see the JP:3349 Stock Forecast page.
More about COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation is a company listed on the Tokyo Stock Exchange, primarily operating in the pharmaceutical industry. The company focuses on providing a range of pharmaceutical products and services, catering to the healthcare market.
Average Trading Volume: 339,066
Technical Sentiment Signal: Buy
Current Market Cap: Yen677.6B
For detailed information about 3349 stock, go to TipRanks’ Stock Analysis page.